Thomas Mensinger v. HHS - Influenza, Guillain-Barre Syndrome (GBS) (2022)
Case summary [AI summaries can sometimes make mistakes]
Katherine Mensinger, as Administrator of the Estate of Thomas Mensinger, filed a petition for compensation under the National Vaccine Injury Compensation Program. She alleged that Thomas Mensinger received an influenza vaccine on November 11, 2017, and subsequently developed Guillain-Barre Syndrome (GBS), which led to his death on February 9, 2018.
The petition stated the vaccine was administered in the United States and that the GBS persisted until his death. Respondent denied that the decedent sustained a GBS Table injury, denied that the flu vaccine caused the GBS or any other injury, and denied that the death was a sequelae of a vaccine-related injury.
Despite these denials, the parties filed a joint stipulation agreeing to a settlement. The court adopted the stipulation as its decision, awarding compensation.
A lump sum of $175,000.00 was awarded to Petitioner as legal representative of the estate. This amount represents compensation for all items of damages available under Section 15(a) of the Vaccine Act.
The parties agreed that this stipulation expresses a full and complete negotiated settlement of liability and damages.
Source PDFs
USCOURTS-cofc-1_20-vv-00138